StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) operating KPIs

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)

Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%

Johnson & Johnson cost of products sold (% to sales) (%)

Form 8-K EX-99.2 Condensed Consolidated Statement of Earnings

QuarterlyAnnual
Latest, FY2025
32.1%
Period ended Dec 28, 2025
Change on a year earlier
+1.2 pts
30.9% in FY2024
History
10 years
Since FY2016
Sources
9
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCost of products sold (% to sales) (%)Year on yearSource
FY2025Dec 28, 202532.1%+1.2 ptsForm 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
FY2024Dec 29, 202430.9%-0.3 ptsForm 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
FY2023Dec 31, 202331.2%+0.5 ptsForm 8-K (a2024q4exhibit991.htm, filed 2025-01-22) ↗
FY2022Jan 1, 202330.7%-1.1 ptsForm 8-K (a2023q4exhibit991.htm, filed 2024-01-23) ↗
FY2021Jan 2, 202231.8%-2.6 ptsForm 8-K (a2022q4exhibit991.htm, filed 2023-01-24) ↗
FY2020Jan 3, 202134.4%+0.8 ptsForm 8-K (a2021q4exhibit991.htm, filed 2022-01-25) ↗
FY2019Dec 29, 201933.6%+0.4 ptsForm 8-K (a2020q4exhibit991.htm, filed 2021-01-26) ↗
FY2018Dec 30, 201833.2%-0.1 ptsForm 8-K (a2019q4exhibit991.htm, filed 2020-01-22) ↗
FY2017Dec 31, 201733.3%+3.1 ptsForm 8-K (a2018q4exhibit9915.htm, filed 2019-01-22) ↗
FY2016Jan 1, 201730.2%–Form 8-K (a8k2017q4exhibit9915.htm, filed 2018-01-23) ↗

Cite this data

StockData. (2026). Johnson & Johnson Cost of products sold (% to sales) (%), annual FY2016–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/gaap_cogs_pct_sales

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.